 |
|
| Blog results | Results 1 - 10 of about 496 for stargardt macular degeneration. (0.18 seconds) |
| Sorted by relevance Sort by date |
| 20 Nov 2009 ... cell technology has employed a line of embryonic stem cells grown from an embryo to generate retinal pigment epithelial cells, a type of eye tissue that fails to function in Stargardt's disease and age-related macular degeneration. ... India Server - News - http://www.india-server.com/ - References |
| 21 Nov 2009 by noreply@blogger.com (World Of Mysteries) The first to benefit will be sufferers of Stargardt's macular degeneration, which destroys the central part of the retina involved in recognising faces and reading words on a page. ACT scientists also intend to follow this with an ... World Of Mysteries - http://worldmysteries9.blogspot.com/ |
| 21 Nov 2009 by DoctorFrog As many as 10 million people in the United States have photoreceptor degenerative disease. While most of these patients have Age-Related Macular Degeneration (AMD), a smaller number of patients have Stargardt's, an Orphan disease and ... Procto-Med - http://www.procto-med.com/ - References |
| 19 Nov 2009 by LD We are optimistic that human embryonic stem cells (hESCs) will serve as a potentially safe and inexhaustible source of RPE for the treatment of a range of macular degenerative diseases.” “We are pleased with the progress we have made in ... Blinding Ambition - http://blindingambition.blogspot.com/ [ More results from Blinding Ambition ] |
| 19 Nov 2009 by Jef Akst In addition, given the similar pathological processes between Stargardt's Macular Dystrophy and age-related macular degeneration, ACT also hopes to file an IND in the next few months to use hESCs in age-related macular degeneration, ... News from The Scientist - http://www.the-scientist.com/ - References |
| 22 Nov 2009 by Henry McCusker The “proposed” trial aims to treat patients with Stargardt's Macular Dystrophy (SMD); a genetic eye disease for which there is currently – NO – treatment and one of the most common causes of “juvenile” blindness,; The disease results in the ... which in turn leads to loss of vision,; This trial will involve a total of 12 patients at 3 clinical sites,; Given the “similar” pathology between Stargardt's Macular Dystrophy and Age-related Macular Degeneration (AMD); ACTC. ... Scimitar Equity Blog - http://www.scimitarequity.com/blog/ - References |
| 19 Nov 2009 by info@sujanani.com “While most of these patients have Age-Related Macular Degeneration (AMD), a smaller number of patients have Stargardt's, an Orphan disease and one of the most common forms of juvenile macular blindness.” “The treatment for eye disease ... LASIK Eye Surgery - http://www.sujanani.com/lasik/lasik_surgery/ [ More results from LASIK Eye Surgery ] |
| 19 Nov 2009 First human stem cell trial using IVF embryos will treat patients facing blindnessDaily MailThe first to benefit will be sufferers of Stargardt's macular degeneration, which destroys the central part of the retina involved in ... Macular Degeneration News - http://macular.lastmed.com/ [ More results from Macular Degeneration News ] |
| 19 Nov 2009 by The San Francisco Sentinel ACT has filed an “investigational new drug” application with the FDA to treat a form of progressive damage to the retina of the eye called Stargardt's macular degeneration, which destroys the central part of the retina involved in ... San Francisco Sentinel - http://www.sanfranciscosentinel.com/ - References |
| 10 Sep 2009 macular degeneration: real life question. Macular Degeneration Questions and Answers - http://www.ahaf.org/ |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
